SARCOPENIA: NO CONSENSUS, NO DIAGNOSTIC CRITERIA, AND NO APPROVED INDICATION HOW DID WE GET HERE?
2024
Understanding Sarcopenia and Its Treatment Challenges
publication
Author Information
Author(s): William Evans
Primary Institution: University of California Berkeley
Hypothesis
What are the reasons for the lack of effective pharmacotherapies for sarcopenia?
Conclusion
There are currently no approved drugs to treat sarcopenia, despite advances in understanding muscle metabolism.
Supporting Evidence
- Skeletal muscle is crucial for movement and metabolic health.
- Sarcopenia is the age-related loss of muscle mass and strength.
- Loss of muscle health is linked to chronic diseases and increased mortality.
Takeaway
As people get older, they lose muscle, which can make them sick and weak, but there are no medicines to help fix this problem yet.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website